These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37958221)

  • 21. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
    Zafrir B; Lund LH; Laroche C; Ruschitzka F; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Seferovic PM; Maggioni AP; De Mora Martin M; Polonski L; Silva-Cardoso J; Amir O;
    Eur Heart J; 2018 Dec; 39(48):4277-4284. PubMed ID: 30325423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.
    Ling LH; Taylor AJ; Ellims AH; Iles LM; McLellan AJ; Lee G; Kumar S; Lee G; Teh A; Medi C; Kaye DM; Kalman JM; Kistler PM
    Heart Rhythm; 2013 Sep; 10(9):1334-9. PubMed ID: 23811081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry.
    Phillips KP; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2020 Feb; 22(2):225-231. PubMed ID: 31665276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procedural Outcomes of Patients With Heart Failure Undergoing Catheter Ablation of Atrial Fibrillation.
    Jayanna MB; Mohsen A; Inampudi C; Alvarez P; Giudici MC; Briasoulis A
    Am J Ther; 2019; 26(3):e333-e338. PubMed ID: 30893071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Angiotensin Receptor-Neprilysin Inhibitor in Arrhythmogenicity Following Left Atrial Appendage Closure in an Animal Model.
    Cheng WH; Lugtu IC; Chang SL; Liu SH; Chen SA; Lo LW
    Cardiovasc Drugs Ther; 2021 Aug; 35(4):759-768. PubMed ID: 33818689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 32. Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation.
    Liu J; Xia Y; Zhang H; Li X; Zhang S; Fang P
    Herz; 2021 Apr; 46(Suppl 1):82-88. PubMed ID: 32002565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure.
    Ichijo S; Miyazaki S; Kusa S; Nakamura H; Hachiya H; Kajiyama T; Iesaka Y
    J Cardiol; 2018 Sep; 72(3):240-246. PubMed ID: 29609877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual flow may increase the risk of adverse events in patients received combined catheter ablation and transcatheter left atrial appendage closure for nonvalvular atrial fibrillation: a meta-analysis.
    Han Z; Wu X; Chen Z; Ji W; Liu X; Liu Y; Di W; Li X; Yu H; Zhang X; Xu B; Lan RF; Xu W
    BMC Cardiovasc Disord; 2019 Jun; 19(1):138. PubMed ID: 31182014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catheter ablation for patients with atrial fibrillation and heart failure with reduced and preserved ejection fraction: insights from the KiCS-AF multicentre cohort study.
    Shiraishi Y; Kohsaka S; Ikemura N; Kimura T; Katsumata Y; Tanimoto K; Suzuki M; Ueda I; Fukuda K; Takatsuki S
    Europace; 2023 Feb; 25(1):83-91. PubMed ID: 35851807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial appendage closure in patients with heart failure and atrial fibrillation: industry-independent single-centre study.
    Saad M; Osman M; Hasan-Ali H; Abdel Ghany M; A Alsherif M; Risha O; Sano M; Fink T; Heeger CH; Vogler J; Sciacca V; Eitel C; Stiermaier T; Joost A; Keelani A; Fuernau G; Saraei R; Kuck KH; Eitel I; Tilz RR
    ESC Heart Fail; 2022 Feb; 9(1):648-655. PubMed ID: 34783164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry.
    von Olshausen G; Benson L; Dahlström U; Lund LH; Savarese G; Braunschweig F
    Eur J Heart Fail; 2022 Sep; 24(9):1636-1646. PubMed ID: 35779270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of 5-year follow-up outcomes between"one-stop"procedure and long-term oral anticoagulants after radiofrequency catheter ablation in patients with atrial fibrillation].
    Zhuo WD; Fu GH; Wang BH; He B; Du XF; Yu YB; Feng MJ; Liu J; Qi YB; Chu HM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Sep; 51(9):951-957. PubMed ID: 37709711
    [No Abstract]   [Full Text] [Related]  

  • 39. One-stop strategy for treatment of atrial fibrillation: feasibility and safety of combining catheter ablation and left atrial appendage closure in a single procedure.
    Chen M; Wang ZQ; Wang QS; Sun J; Zhang PP; Feng XF; Li W; Yu Y; Liu B; Mo BF; Zhang R; Yang M; Gong CQ; Zhao MZ; Yu YC; Zhao Y; Lu QF; Li YG
    Chin Med J (Engl); 2020 Jun; 133(12):1422-1428. PubMed ID: 32433041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Left Atrial Appendage Closure and Oral Anticoagulation After Atrial Fibrillation Catheter Ablation.
    Fei ZT; Yao PC; Qiu JH; Chen M; Fei YD; Li W; Zhang PP; Sun J; Wang QS; Li YG
    Am J Cardiol; 2023 Oct; 204():312-319. PubMed ID: 37567023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.